The pharmaceutical industry is currently experiencing a crisis in the identification of novel compounds that successfully make their way through clinical drug development to regulatory approval.

Fragment-based drug discovery (FBDD) was introduced a decade ago and is a promising method of identifying high-quality lead compounds.

Download this list to:

• Discover the principles of FBDD
• Learn how FBDD compares to other drug discovery approaches
• Explore the various techniques that allow for lead compound identification with FBDD